Finasteride is the most studied and most debated hair loss drug on the planet. Approved by the FDA in 1997, it's been the subject of intense clinical scrutiny — and equally intense internet anxiety. Here's what the evidence actually says, stripped of the marketing and the fear.
Finasteride works by blocking the enzyme 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). DHT is the hormone primarily responsible for miniaturizing hair follicles in men with androgenetic alopecia. By reducing DHT levels by approximately 60–70%, finasteride slows or halts the follicular shrinkage that causes visible hair loss.
The Efficacy Numbers
Phase III clinical trials involving 1,879 men provide the most robust efficacy data.
Sources: DermNet NZ Finasteride Review; ISHRS Treatment Guidelines; PubMed ID: 9951956.
In the landmark phase III studies, visible hair growth improvement was observed in 48% of men at 1 year. At 2 years, 66% of finasteride users showed improvement versus 7% on placebo. Only 14% of men on finasteride experienced further hair loss after 12 months, compared to 58% on placebo.
Finasteride vs. Placebo: Outcomes at 2 Years
Phase III trials, 1,879 men with mild-to-moderate vertex hair loss
The Side Effect Reality
The overall rate of treatment-related adverse events was 7.7% for finasteride users versus 7.0% for placebo — a difference that is barely statistically significant. The side effects that matter most are the sexual ones.
Finasteride (1mg/day)
Placebo
Source: DermNet NZ; Phase III data from 1,879 men. A 2017 study of 3,177 men found an even lower 0.7% incidence of side effects.
The Post-Finasteride Syndrome Debate
Post-finasteride syndrome (PFS) — persistent sexual, neurological, and psychological side effects after stopping finasteride — is the most contentious topic in hair loss treatment. The clinical evidence for PFS as a widespread phenomenon remains limited. Most hair restoration surgeons report it as rare in their practice. The discrepancy between clinical trials and online patient reports remains an open question.
What the Science Supports
Sexual side effects occur in a real but small minority of users (approximately 2–4% above placebo). They typically resolve after stopping the medication. Anyone considering finasteride should have an informed conversation with their prescribing physician about their personal risk factors.
What to Expect: The Treatment Timeline
DHT levels drop within weeks. Some men experience temporary increased shedding as the follicle cycle resets. This is normal.
Earliest visible results may appear. Shedding normalizes. Most clinicians say too early to judge efficacy.
Meaningful results become visible for responders. Hair count and density improvements are measurable.
Peak improvement typically achieved by year 2. If no improvement after 12 months, the medication is unlikely to be effective.
Benefits maintained with continued use. 65% of men maintained positive results at 5 years.
Who It Works Best For
Finasteride is most effective for men with mild to moderate hair loss — particularly thinning at the crown and anterior mid-scalp. Combining finasteride with minoxidil produces better outcomes than either treatment alone.
The Bottom Line
Finasteride is the most evidence-backed pharmaceutical treatment for male pattern baldness. It works for the majority of men, especially when started early. Side effects are real but affect a small minority, and typically resolve with discontinuation. It is not a cure — it requires ongoing use to maintain results. As with any prescription medication, this decision belongs to you and your doctor.